Jan 27, 2020
Asia-Pacific Seasonal Influenza Vaccines Markets, 2018-2028: Overview, Topline Market Revenue, Pipeline Analysis, Current & Future Market Competition
Jan 24, 2020
Seasonal Influenza Vaccines: Forecast in Asia-Pacific Markets to 2028
Dec 09, 2019
Sanofi awarded $226 million by US government to expand pandemic influenza preparedness
Dec 02, 2019
Seasonal Influenza Vaccines: Global Drug Forecast and Market Analysis to 2028
Oct 01, 2019
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine
Jul 15, 2019
GSK ships 2019-20 seasonal influenza vaccines for US market
Apr 25, 2019
Medicago Awarded "Best New Vaccine Technology/Platform" at the World Vaccine Congress
Jan 23, 2019
FDA approves use of 0.5 mL dose of Fluzone® Quadrivalent (influenza vaccine) in children as young as 6 months of age
Nov 16, 2018
Seqirus Releases Real-World Data Indicating Significantly Greater Effectiveness of Cell-Based Seasonal Influenza Vaccines Compared to Standard Influenza Vaccine Options
Oct 23, 2018
Seqirus Receives FDA Approval of AFLURIA® QUADRIVALENT (Influenza Vaccine) for People Six Months of Age and Older in the U.S.
Oct 01, 2018
GC Pharma Receives Korea's MFDS Approval of GCFLU Quadrivalent (Influenza Vaccine) for persons 6 months and older
Aug 08, 2018
GSK ships 2018-19 seasonal influenza vaccines for US market
Aug 08, 2018
Seqirus Begins Shipping 2018-2019 Influenza Vaccines to the U.S. Market
Aug 07, 2018
Influenza Vaccine Market to Reach USD 11.4 Billion by 2025
Jul 30, 2018
Sanofi Ships First Flu Vaccines for 2018-2019 Season
May 18, 2018
Eurocine Vaccines has Completed Dosing of its Quadrivalent Influenza Vaccine Candidate, Immunose(TM) FLU, in the Second Clinical Study
Apr 25, 2018
FDA accepts for review Supplemental Biologics License Application for 0.5 mL dose of Fluzone® Quadrivalent (Influenza Vaccine) in children 6-35 months of age